We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.64B
AUM Growth
+$69.3M
Cap. Flow
+$163M
Cap. Flow %
6.15%
Top 10 Hldgs %
15.9%
Holding
1,827
New
629
Increased
253
Reduced
185
Closed
664

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$46.9M
2
PBCT
People's United Financial Inc
PBCT
+$42.2M
3
MMM icon
3M
MMM
+$39.9M
4
LOW icon
Lowe's Companies
LOW
+$38.4M
5
EMR icon
Emerson Electric
EMR
+$35.8M

Top Sells

Rank Stock Value
1
EPAM icon
EPAM Systems
EPAM
+$40.2M
2
DHR icon
Danaher
DHR
+$37.9M
3
SO icon
Southern Company
SO
+$37.6M
4
KLAC icon
KLA
KLAC
+$33.8M
5
WFC icon
Wells Fargo
WFC
+$31.8M

Sector Composition

Rank Sector Weight
1 Technology 19.33%
2 Financials 16.14%
3 Industrials 11.04%
4 Consumer Discretionary 7.83%
5 Healthcare 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUS
726
DELISTED
Austerlitz Acquisition Corporation I
AUS
$421K 0.02%
42,916
+1,132
+3% +$11K
WK icon
727
Workiva
WK
$3.13B
$420K 0.02%
3,558
-7,325
-67% -$810K
RMBI icon
728
Richmond Mutual Bancorp
RMBI
$247M
$419K 0.02%
24,532
-14,335
-37% -$240K
TSN icon
729
Tyson Foods
TSN
$21.4B
$419K 0.02%
4,670
+1,363
+41% +$124K
BRX icon
730
Brixmor Property Group
BRX
$9.93B
$417K 0.02%
16,141
-16,645
-51% -$420K
NSC icon
731
Norfolk Southern
NSC
$77.1B
$417K 0.02%
+1,462
New +$403K
UDMY
732
DELISTED
Udemy
UDMY
$417K 0.02%
+33,500
New +$463K
FN icon
733
Fabrinet
FN
$16.9B
$416K 0.02%
+3,957
New +$418K
TSAT icon
734
Telesat
TSAT
$575M
$416K 0.02%
+25,200
New +$562K
ASB icon
735
Associated Banc-Corp
ASB
$5.78B
$415K 0.02%
18,231
-22,365
-55% -$541K
PNTG icon
736
Pennant Group
PNTG
$1.44B
$415K 0.02%
+22,300
New +$372K
FSK icon
737
FS KKR Capital
FSK
$3.04B
$414K 0.02%
+18,153
New +$402K
RVMD icon
738
Revolution Medicines
RVMD
$40B
$411K 0.02%
16,100
-195
-1% -$4.24K
BLMN icon
739
Bloomin' Brands
BLMN
$731M
$410K 0.02%
18,690
+181
+1% +$3.9K
RIGL icon
740
Rigel Pharmaceuticals
RIGL
$692M
$410K 0.02%
13,716
+5,889
+75% +$159K
DCPH
741
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$407K 0.02%
43,900
+31,908
+266% +$271K
QCRH icon
742
QCR Holdings
QCRH
$1.65B
$406K 0.02%
+7,169
New +$409K
AKAM icon
743
Akamai
AKAM
$16.4B
$405K 0.02%
+3,392
New +$380K
ERII icon
744
Energy Recovery
ERII
$439M
$405K 0.02%
+20,100
New +$391K
NWN icon
745
Northwest Natural Holdings
NWN
$2.16B
$403K 0.02%
+7,800
New +$391K
WU icon
746
Western Union
WU
$2.55B
$403K 0.02%
21,529
+6,042
+39% +$112K
SPTKU
747
DELISTED
SportsTek Acquisition Corp. Unit
SPTKU
$403K 0.02%
40,989
GERN icon
748
Geron
GERN
$949M
$402K 0.02%
295,715
+210,488
+247% +$235K
D icon
749
Dominion Energy
D
$61.8B
$401K 0.02%
4,719
+146
+3% +$11.7K
CLDX icon
750
Celldex Therapeutics
CLDX
$2.8B
$399K 0.02%
11,702
-4,459
-28% -$143K

Similar funds

Ergoteles's Q1 2022 Portfolio in Review

As of Q1 2022, Ergoteles held 1,827 positions worth $2.64B, up 2.7% from $2.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ergoteles deployed $163M of net new capital in Q1 2022, opening 629 new positions and adding to 253 existing holdings. Its largest new stake was 3M: 299,716 shares worth $37.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Danaher, an estimated $37.9M trimmed.

  • Ergoteles's largest Q1 2022 buy was 3M: 299,716 shares worth $37.3M.
  • Ergoteles added most to Oracle in Q1 2022, an estimated $46.9M increase.
  • Ergoteles's biggest Q1 2022 reduction was Danaher, cutting an estimated $37.9M.
  • Ergoteles fully exited EPAM Systems in Q1 2022, selling an estimated $40.2M.
  • Ergoteles's ten largest holdings make up 16% of its $2.64B portfolio in Q1 2022.
  • Ergoteles opened 629 new positions and closed 664 in Q1 2022.
  • Ergoteles's portfolio value rose 2.7% quarter-over-quarter to $2.64B.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.